N-Acetyl Semax Amidate

N-Acetyl Semax Amidate is a modified analog of Semax, itself derived from the ACTH(4-7) fragment. It is considered the most potent and bioavailable form of Semax, incorporating both N-terminal acetylation and C-terminal amidation to resist enzymatic degradation. Used intranasally, it is studied for cognitive enhancement, neuroprotection, BDNF upregulation, and focus and mood improvement.

N-Acetyl Semax Amidate modulates neurotrophic and neurogenic signaling primarily through upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, as well as nerve growth factor (NGF) and GAP-43. These effects promote neuroplasticity, synaptic density, and long-term potentiation. It also influences the melanocortin system via partial ACTH-receptor agonism, which affects mood, attention, and stress response. The acetyl and amide modifications substantially extend half-life compared to unmodified Semax (estimated 6–12 hours vs. 2–4 hours) by blocking aminopeptidase and carboxypeptidase cleavage sites. Dopaminergic and serotonergic modulation has been reported in preclinical models.

Semax and its analogs have been approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease. Human studies (primarily Russian) demonstrate improvements in attention, processing speed, and memory consolidation. Animal models show neuroprotective effects following ischemic injury, increased BDNF expression in the hippocampus, and reduced neuroinflammation. N-Acetyl Semax Amidate's enhanced pharmacokinetics make it the preferred form in community biohacking protocols, though Western double-blind RCT data specific to this analog remain limited as of 2026.

Peptides commonly paired with N-Acetyl Semax Amidate for synergistic effects.